Affiliation:
1. Institute for Wearable Convergence Electronics College of Electronics and Information Kyung Hee University Yongin Gyeonggi Republic of Korea
2. EzDiaTech Inc. Anyang Gyeonggi Republic of Korea
3. Department of Electronics and Information Convergence Engineering Kyung Hee University Yongin Gyeonggi Republic of Korea
4. Department of Electronic Engineering Kyung Hee University Yongin Gyeonggi Republic of Korea
Abstract
AbstractThe ELISA is the most worldwide method for immunoassay. However, the ELISA is losing ground due to low reproducibility of manual experimental processes in both R&D and IVD areas. An automated platform is a good solution, but there are still limitations owning to extremely high cost and requiring large space to set up especially for a small size laboratory. Here, we present a novel all‐in‐one platform called “VEUS” settable on the laboratory table that offers comprehensive automation of the entire multiplex immunoassay process by exploiting antibody conjugated magnetic particles, quality control and then immunoanalytical reaction, thereby enhancing detection sensitivity and high reproducibility. As a proof of concept, the system exhibits a sensitive LOD of 0.6 and 3.1 pg mL−1 within 1 h run, comparable precision that of molecular diagnostic systems based on PCR method, enabling rapid multiplex diagnosis of Influenza A, Influenza B, and COVID‐19 viruses with similar symptoms. Through automation by the all‐in‐one system, it can be used by novice users, something innovative for immunoassays, relying heavily on user experience. Furthermore, it can contribute to streamline entire immunoassay processes of diverse biomarkers with high reproducibility and convenience in laboratories.
Funder
Ministry of SMEs and Startups
National Research Foundation of Korea